Kissing stents in the aortic bifurcation - 09/09/11
Abstract |
Background We report the first series of simultaneously delivered stents used to treat stenosis of the aortic bifurcation. Surgical treatment of aortoiliac occlusive disease carries up to a 3% mortality rate. Percutaneous balloon techniques to treat aortic bifurcation stenosis, although safer, are still associated with up to a 9% incidence of dissection, thrombosis, or significant residual stenosis. Kissing stent insertion should decrease the incidence of these complications. Methods Twenty patients underwent kissing stent insertion. Suitable candidates included patients with symptoms of lower limb ischemia and significant atherosclerotic lesions in both ostial common iliac arteries (n = 15) or with extremely complex single ostial iliac stenoses (n = 5). Palmaz stents were delivered simultaneously to both limbs of the aortic bifurcation. Results Kissing stent insertion was successfully performed in all 20 patients without acute complications. Mean percent stenosis decreased from 46.2% ± 24.8% to –6.8% ± 13.3% (P = .0001) in the right iliac artery, 42.3% ± 22.8% to –1.6% ± 18.1% (P = .0001) in the left iliac artery, and 19.1% ± 16.6% to 2.3% ± 16.4% (P = .0008) in the distal aorta. Intermittent claudication symptoms were improved in 18 (95%) of 19 patients with 12 (63%) of 19 patients becoming totally asymptomatic. The strongest predictor of clinical outcome after kissing stent insertion was the preprocedural extent of femoropopliteal disease: 8 (89%) of 9 patients with femoropopliteal narrowing <75% bilaterally became completely asymptomatic at follow-up compared with only 3 (30%) of 10 patients with more severe stenoses (P = .02). Conclusions We have demonstrated in 20 patients that stenoses of the aortic bifurcation can be treated effectively with kissing stents with few serious adverse events. (Am Heart J 1998;136:600-5.)
Le texte complet de cet article est disponible en PDF.Plan
From the aDivision of Cardiology, Department of Medicine, Duke University Medical Center, and the bDivision of Cardiology, Department of Medicine, Georgetown University Medical Center. |
|
Supported by the NIH, National Research Service Award 2T32HL07101-21A from the National Heart, Lung, and Blood Institute. |
|
Reprint requests: Farrell O. Mendelsohn, MD, Box 3111, Duke University Medical Center, Durham, NC 27710. |
|
4/1/90604 |
Vol 136 - N° 4
P. 600-605 - octobre 1998 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?